Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation

Neurochemical Research

Volumn 21, Issue 11, 1996, Pages 1411-1415

  Azaryan, Anahit V ^a   Clock, Barbara J ^a   Cox, Brian M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cocaine; mu opioid receptor mRNA; nafadotride; nucleus accumbens; R(+) 6 Bromo APB hydrobromide; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; COCAINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MU OPIATE RECEPTOR; NAFADOTRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0029857332     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532382     Document Type: Article

References (43)

1. Azaryan, A. V., Coughlin, L. J., Búzás, B., Clock, B. J., and Cox, B. M. 1996. Effect of chronic cocaine treatment on μ- and δ-opioid receptor mRNA levels in dopaminergically innervated brain regions. J. Neurochem. 66:443-448.
2. Azaryan, A. V., Clock, B. J., and Cox, B. M. 1996. Transient upregulation of mu opioid receptor mRNA in nucleus accumbens during chronic cocaine administration. FASEB J. 10: p. A448.
3. Griffon, N., Diaz, J., Levesque, D., Sautel, F., Schwartz, J.-C., Sokoloff, P., Simon, P., Costentin, J., Garrido, F., Mann, A., and Wermuth, C. 1995. Localization, regulation and role of the dopamine D3 receptor are distinct from those of the D2 receptor. Clinical Neuropharmac. 18:S130-S142.
4. Sokoloff, P. and Schwartz, J.-C. 1995. Novel dopamine receptors: half a decade later. Trends Pharm. Sci. 16:270-275.
5. Ritz, M. C., Lamb, R. Y., Goldberg, S. R., and Kuhar, M. J. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
6. Kuhar, M. J., Ritz, M. C., and Boja, J. W. 1991. The dopamine hypothesis of reinforcing properties of cocaine. Trends Neuroscience 14:299-302.
7. Unterwald, E. M., Ho, A., Rubenfeld, J. M., and Kreek, M. J. 1994a. Time course of the development of behavioral sensitization and dopamine receptor upregulation during binge cocaine administration. J. Pharm. Exp. Therap. 270:1387-1397.
8. Meador-Woodruff, J. H., Little, K. Y., Damask, S. P., and Watson, S. J. 1995. Effects of cocaine on D3 and D4 receptor in rat striaturn. Biol. Psychiatry 38:263-266.
9. Sivam, S. P. 1989. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharm. Exp. Therap. 250:818-824.
10. Smiley, P. L., Johnson, M., Bush, L., Gibb, J. W., and Hanson, G. R. 1990. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharm. Exper. Therap. 253:938-943.
11. Hurd, Y. L., Brown, E. E., Finlay, J. M., Fibiger, H. C., and Gerfen, C. R. 1992. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Molec. Brain Res. 13: 165-170.
12. Spangler, R., Unterwald, E. M., and Kreek, M. J. 1993. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19:323-327.
13. Romualdi, P., Donatini, A., Izenwasser, S., Cox, B. M., and Ferri, S. 1996. Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen. Mol. Brain Res., in press.
14. Hammer, Jr. P. P. 1989. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3:55-60.
15. 3H-naloxone binding in brain membranes isolated from spontaneously hypertensive and Wistar-Kyoto rats. Life Sci. 43:2275-2282.
16. Unterwald, E. M., Rubenfeld, J. M., and Kreek, M. J. 1994b. Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. NeuroReport 5:1613-1616.
17. Chromczynsky, P. and Sacchi, N. 1987. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
18. Siebert, P. D. and Larrick, J. W. 1992. Competitive PCR. Nature 359:557-558.
19. Búzás, B. and Cox, B. M. 1994. Competitive PCR assay for quantitation of mu and delta opioid receptor messenger-RNA levels in small tissue samples. Regulatory Peptides 54:35-36.
20. Búzás, B., and Cox, B. M. 1996. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neurosci., in press.
21. Zahm, D. S., and Brog, J. S. 1992. Commentary: On the significance of subterritories in the accumbens part of the ventral striaturn. Neuroscience 50:751-767.
22. Koob, G. F., and Goeders, N. E. 1988. Neuroanatomical substrates of drug self-administration. Pages 214-263, Liebman, J. M., and Cooper, S. J. (ed) in Neuropharmacological Basis of Reward. Oxford University Press, New York.
23. Koob, G. F. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Neurosci. 13:177-184.
24. Wise, R. A., and Bozarth, M. A. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:469-492.
25. Cooper, S. J. 1991. Interactions between endogenous opioids and dopamine: Implications for reward and aversion. Pages 331-366, in The Mesolimbic Dopamine System: From Motivation to Action. John Wiley and Sons, Ltd. London.
26. Meador-Woodruff, J. H., Grandy, D. K., Van Toi, H. H. M., Damask, B., Karley, S., Little, Y., Civelli, O., Watson, S. J. 1994. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10:239-248.
27. Curran, E. J., and Watson, S. J. 1995. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361:57-76.
28. Chen, Y., Mestek, A., Liu, J., Hurley, J., and Yu, L. 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:8-12.
29. Mansour, A., Fox, C. A., Thompson, R. C., Akil, H., Watson, S. J. 1994. μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ receptor binding. Brain Res. 643:245-265.
30. Mansour, A., Fox, C. A., Burke, S., Akil, H., and Watson, S. J. 1995. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8:283-305.
31. Arvidsson, U., Riedl, M., Chacrabarti, S., Lee, J.-H., Nakano, A. H., Dado, R. J., Loh, H. H., Law, P.-Y, Wessendorf, M. W., and Elde, R. 1995. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:3328-3341.
32. Self, D. W., and Stein, L. 1992. The D1 agonists SKF 89258 and SKF 77434 are self-administered by rats. Brain Res. 582:349-352.
33. Self, D. W., Belluzzi, J. D., Kossuth, S., Stein, L. 1996. Self-administration of the D-1 agonist SKF 82958 is mediated by D-1, not by D-2, receptors. Psychopharmacol. 123:303-306.
34. Rozenweig-Lipson, S., Hesterberg, P., Bergman, J. 1994. Observational studies of dopamine D1 and D2 agonists in squirrel monkeys. Psychopharmacol. 116:9-18.
35. Britton, D. R., Curzon, P., Mackenzie, R. G., Kebabian, J. W., Williams, J. E., and Kerkman, D. 1991. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmac. Biochem. Behavior 39:911-915.
36. 1dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45:239-242.
37. Hubner, C. B., and Koob, G. F. 1990. Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychopharmacol. 3:101-108.
38. Callahan, P. M., and Cunningham, K. A. 1993. Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J. Pharm. Exp. Therap. 266:585-592.
39. Lahti, R., Roberts, R., and Taminga, C. 1995. D2 family receptor distribution in human postmortem tissue: an autoradiographic study. NeuroReport 6:2505-2512.
40. Shetreat M., Lil, L., Wong, A., and Rayport, S. 1996. Visualization of D1 dopamine receptors on living nucleus accumbens neurons and their colocalization with D2 receptors. J. Neurochem. 66: 1475-1482.
41. Bouthenet, M. L., Souil, E., Martres, M. P., Sokoloff, P., Giros, B., Schwartz, J. C. 1991. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564: 203-219.
42. Landwehrmeyer, B., Mengod, G., Palacios, J. M. 1993. Differential visualization of dopamine D2 and D3 receptor sites in rat brain: a comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5:145-153.
43. Diaz, J., Levesque, D., Lammers, C. H., Griffon, N., Martres, M.-P., Schwartz, J.-C., Sokoloff, P. 1995. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neurosci. 65:731-745.